Adopting the Oncology Care Model (OCM) is a challenging task for oncology practices that have to redesign their practices, but the shift from volume-based to value-based care is the way of the future, said Kashyap Patel, MD, of the Carolina Blood & Cancer Center.
Adopting the Oncology Care Model (OCM) is a challenging task for oncology practices that have to redesign their practices, but the shift from volume-based to value-based care is the way of the future, said Kashyap Patel, MD, of the Carolina Blood & Cancer Center.
Transcript (slightly modified)
What was the most challenging part about preparing and adopting the Oncology Care Model across networks of practices?
So, Oncology Care Model had many unknowns, primarily because it’s completely new, episode-based care model. Before the actual application process began, there were so many labor-intensive quality reporting parameters that we thought we had to do, so preparing for the completely unknown way of practicing medicine and bringing the entire practice on board, because we are 5 oncologists, we have a lot of staff. And to be able to convince everyone this is the way of the future was the most challenging part for our transition process from volume to value-based care.
Did adopting the OCM require significant process changes? What were the most challenging workflow changes?
So prior to implementation of the OCM plan, we had to rethink the way we treated patients. The OCM plan is the first step towards shifting from volume to value, and it requires changing the way we treated patients. And anytime, change is always hard, and if it’s one person has to change it’s a different story, but to be able to change the entire practice, allowing patients to walk in for the same-day appointments, expanding the access so that we can deal with any unexpected emergency when it arises, were all processes that we had to completely redesign, so it definitely was a task.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More